ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ADAP Advocacy Airs Commercial Calling Out Excessive Executive Compensation for 340B-Eligible Hospital CEOs





Commercial: Is the 340B Drug Pricing Program the Next 'Too Big to Fail'?

WASHINGTON, DC, October 23, 2025 /24-7PressRelease/ -- ADAP Advocacy today, as part of its 340B Project, aired its latest commercial calling for reforms to the 340B Drug Pricing Program. The commercial calls out excessive executive compensation for 340B-eligible hospital CEOs, asking a critical question: "Is the 340B Drug Pricing Program the Next 'Too Big to Fail'?"

Brandon M. Macsata, CEO of ADAP Advocacy, summarized: "Hospital CEOs are being compensated 200-300% more than the nurses providing the direct patient care, and sometimes even above, largely financed by a program designed to help low-income patients access healthcare services. Anyone who suggests the 340B program isn't benefiting providers and their executives more than patients is being intellectually dishonest. Patients learn about this level of pay and compare it to the medical debt that they're carrying, and it literally makes them sick."

The new commercial is part of the '340B Too Big To Fail' national advocacy campaign, which will run through the end of the year, highlighting hospitals' declining charity, rising healthcare executive compensation, and exploding patient medical debt, among some other issues. ADAP Advocacy's interactive map has elevated these trends.

The commercial is available online at https://youtu.be/Q8zaGIZqDp4.

To learn more about ADAP Advocacy, 340B Drug Pricing Program, excessive hospital CEO pay, or the new 340B commercial, please email info@adapadvocacy.org.

About ADAP Advocacy: ADAP Advocacy's mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. ADAP Advocacy works with advocates, community, health care, government, patients, pharmaceutical companies, and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.89
+2.68 (1.20%)
AAPL  265.13
+2.31 (0.88%)
AMD  253.88
+0.97 (0.38%)
BAC  52.77
+0.20 (0.39%)
GOOG  267.60
+7.09 (2.72%)
META  751.39
+13.03 (1.76%)
MSFT  532.66
+9.05 (1.73%)
NVDA  191.03
+4.78 (2.56%)
ORCL  282.85
-0.48 (-0.17%)
TSLA  455.44
+21.72 (5.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.